nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—CYP1A2—type 2 diabetes mellitus	0.171	0.602	CbGaD
Apixaban—CYP3A4—type 2 diabetes mellitus	0.113	0.398	CbGaD
Apixaban—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0236	0.044	CbGbCtD
Apixaban—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0189	0.0352	CbGbCtD
Apixaban—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0179	0.0334	CbGbCtD
Apixaban—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0171	0.0318	CbGbCtD
Apixaban—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0168	0.0314	CbGbCtD
Apixaban—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0165	0.0307	CbGbCtD
Apixaban—ABCG2—Glyburide—type 2 diabetes mellitus	0.0164	0.0305	CbGbCtD
Apixaban—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.016	0.0298	CbGbCtD
Apixaban—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0158	0.0293	CbGbCtD
Apixaban—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0152	0.0283	CbGbCtD
Apixaban—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0151	0.028	CbGbCtD
Apixaban—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0143	0.0267	CbGbCtD
Apixaban—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0143	0.0267	CbGbCtD
Apixaban—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.014	0.0261	CbGbCtD
Apixaban—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0135	0.0251	CbGbCtD
Apixaban—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0132	0.0246	CbGbCtD
Apixaban—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0128	0.0238	CbGbCtD
Apixaban—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0124	0.0231	CbGbCtD
Apixaban—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0122	0.0227	CbGbCtD
Apixaban—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0119	0.0222	CbGbCtD
Apixaban—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0119	0.0222	CbGbCtD
Apixaban—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0116	0.0215	CbGbCtD
Apixaban—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.011	0.0205	CbGbCtD
Apixaban—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0107	0.02	CbGbCtD
Apixaban—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0106	0.0198	CbGbCtD
Apixaban—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0097	0.0181	CbGbCtD
Apixaban—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0096	0.0179	CbGbCtD
Apixaban—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00957	0.0178	CbGbCtD
Apixaban—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00908	0.0169	CbGbCtD
Apixaban—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00902	0.0168	CbGbCtD
Apixaban—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00876	0.0163	CbGbCtD
Apixaban—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00865	0.0161	CbGbCtD
Apixaban—CYP3A5—Losartan—type 2 diabetes mellitus	0.00831	0.0155	CbGbCtD
Apixaban—CYP2C8—Losartan—type 2 diabetes mellitus	0.00799	0.0149	CbGbCtD
Apixaban—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00794	0.0148	CbGbCtD
Apixaban—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00765	0.0143	CbGbCtD
Apixaban—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00733	0.0137	CbGbCtD
Apixaban—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00692	0.0129	CbGbCtD
Apixaban—CYP2C19—Losartan—type 2 diabetes mellitus	0.0067	0.0125	CbGbCtD
Apixaban—CYP1A2—Losartan—type 2 diabetes mellitus	0.00619	0.0115	CbGbCtD
Apixaban—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00609	0.0114	CbGbCtD
Apixaban—ABCB1—Glyburide—type 2 diabetes mellitus	0.00591	0.011	CbGbCtD
Apixaban—CYP2C9—Losartan—type 2 diabetes mellitus	0.00557	0.0104	CbGbCtD
Apixaban—ABCB1—Losartan—type 2 diabetes mellitus	0.00541	0.0101	CbGbCtD
Apixaban—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00525	0.00977	CbGbCtD
Apixaban—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00503	0.00937	CbGbCtD
Apixaban—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00503	0.00937	CbGbCtD
Apixaban—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00476	0.00886	CbGbCtD
Apixaban—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00354	0.0066	CbGbCtD
Apixaban—CYP3A4—Losartan—type 2 diabetes mellitus	0.00324	0.00604	CbGbCtD
Apixaban—CYP2J2—artery—type 2 diabetes mellitus	0.00134	0.181	CbGeAlD
Apixaban—F10—cardiovascular system—type 2 diabetes mellitus	0.00057	0.0768	CbGeAlD
Apixaban—CYP2J2—nephron tubule—type 2 diabetes mellitus	0.00052	0.0701	CbGeAlD
Apixaban—F10—adipose tissue—type 2 diabetes mellitus	0.000503	0.0677	CbGeAlD
Apixaban—CYP2J2—cardiovascular system—type 2 diabetes mellitus	0.000467	0.063	CbGeAlD
Apixaban—F10—liver—type 2 diabetes mellitus	0.000353	0.0475	CbGeAlD
Apixaban—Thrombocytopenia—Repaglinide—type 2 diabetes mellitus	0.000328	0.00365	CcSEcCtD
Apixaban—Immune system disorder—Sitagliptin—type 2 diabetes mellitus	0.000328	0.00365	CcSEcCtD
Apixaban—Mediastinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000327	0.00364	CcSEcCtD
Apixaban—Skin disorder—Repaglinide—type 2 diabetes mellitus	0.000325	0.00362	CcSEcCtD
Apixaban—Connective tissue disorder—Bromocriptine—type 2 diabetes mellitus	0.000323	0.00359	CcSEcCtD
Apixaban—Rash—Miglitol—type 2 diabetes mellitus	0.000322	0.00358	CcSEcCtD
Apixaban—Dermatitis—Miglitol—type 2 diabetes mellitus	0.000322	0.00358	CcSEcCtD
Apixaban—Breast disorder—Orlistat—type 2 diabetes mellitus	0.00032	0.00356	CcSEcCtD
Apixaban—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.000317	0.00352	CcSEcCtD
Apixaban—Nervous system disorder—Rosiglitazone—type 2 diabetes mellitus	0.000311	0.00346	CcSEcCtD
Apixaban—Thrombocytopenia—Rosiglitazone—type 2 diabetes mellitus	0.00031	0.00345	CcSEcCtD
Apixaban—Eye disorder—Bromocriptine—type 2 diabetes mellitus	0.000307	0.00342	CcSEcCtD
Apixaban—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.000305	0.00339	CcSEcCtD
Apixaban—Syncope—Glipizide—type 2 diabetes mellitus	0.000305	0.00339	CcSEcCtD
Apixaban—Nausea—Miglitol—type 2 diabetes mellitus	0.000303	0.00338	CcSEcCtD
Apixaban—Liver function test abnormal—Metformin—type 2 diabetes mellitus	0.000301	0.00335	CcSEcCtD
Apixaban—Anaemia—Pioglitazone—type 2 diabetes mellitus	0.000301	0.00335	CcSEcCtD
Apixaban—Loss of consciousness—Glipizide—type 2 diabetes mellitus	0.000299	0.00332	CcSEcCtD
Apixaban—Angiopathy—Bromocriptine—type 2 diabetes mellitus	0.000298	0.00332	CcSEcCtD
Apixaban—Mediastinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000296	0.00329	CcSEcCtD
Apixaban—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.000296	0.00329	CcSEcCtD
Apixaban—Breast disorder—Metformin—type 2 diabetes mellitus	0.000295	0.00328	CcSEcCtD
Apixaban—Anaemia—Glimepiride—type 2 diabetes mellitus	0.000293	0.00326	CcSEcCtD
Apixaban—Rash—Tolbutamide—type 2 diabetes mellitus	0.00029	0.00322	CcSEcCtD
Apixaban—Gastrointestinal disorder—Repaglinide—type 2 diabetes mellitus	0.000289	0.00322	CcSEcCtD
Apixaban—CYP2J2—liver—type 2 diabetes mellitus	0.000289	0.0389	CbGeAlD
Apixaban—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.000285	0.00317	CcSEcCtD
Apixaban—Liver function test abnormal—Irbesartan—type 2 diabetes mellitus	0.000284	0.00316	CcSEcCtD
Apixaban—Hepatobiliary disease—Gliclazide—type 2 diabetes mellitus	0.000284	0.00316	CcSEcCtD
Apixaban—Epistaxis—Gliclazide—type 2 diabetes mellitus	0.000283	0.00315	CcSEcCtD
Apixaban—Eye disorder—Glyburide—type 2 diabetes mellitus	0.000281	0.00312	CcSEcCtD
Apixaban—Loss of consciousness—Glimepiride—type 2 diabetes mellitus	0.000279	0.0031	CcSEcCtD
Apixaban—Breast disorder—Irbesartan—type 2 diabetes mellitus	0.000278	0.00309	CcSEcCtD
Apixaban—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000276	0.00307	CcSEcCtD
Apixaban—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000276	0.00307	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Pioglitazone—type 2 diabetes mellitus	0.000275	0.00306	CcSEcCtD
Apixaban—Gastrointestinal disorder—Rosiglitazone—type 2 diabetes mellitus	0.000273	0.00304	CcSEcCtD
Apixaban—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000273	0.00304	CcSEcCtD
Apixaban—Shock—Glipizide—type 2 diabetes mellitus	0.000273	0.00303	CcSEcCtD
Apixaban—Thrombocytopenia—Glipizide—type 2 diabetes mellitus	0.000271	0.00302	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Sitagliptin—type 2 diabetes mellitus	0.000267	0.00297	CcSEcCtD
Apixaban—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.000266	0.00295	CcSEcCtD
Apixaban—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000263	0.00293	CcSEcCtD
Apixaban—Rash—Tolazamide—type 2 diabetes mellitus	0.000263	0.00293	CcSEcCtD
Apixaban—Breast disorder—Losartan—type 2 diabetes mellitus	0.000262	0.00291	CcSEcCtD
Apixaban—Rash—Linagliptin—type 2 diabetes mellitus	0.000261	0.0029	CcSEcCtD
Apixaban—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00026	0.0029	CcSEcCtD
Apixaban—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.00026	0.0029	CcSEcCtD
Apixaban—Epistaxis—Valsartan—type 2 diabetes mellitus	0.00026	0.0029	CcSEcCtD
Apixaban—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.000259	0.00288	CcSEcCtD
Apixaban—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.000258	0.00287	CcSEcCtD
Apixaban—Hepatobiliary disease—Orlistat—type 2 diabetes mellitus	0.000258	0.00287	CcSEcCtD
Apixaban—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.000258	0.00287	CcSEcCtD
Apixaban—Syncope—Bromocriptine—type 2 diabetes mellitus	0.000256	0.00285	CcSEcCtD
Apixaban—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000256	0.00285	CcSEcCtD
Apixaban—Shock—Glimepiride—type 2 diabetes mellitus	0.000255	0.00283	CcSEcCtD
Apixaban—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	0.000253	0.00282	CcSEcCtD
Apixaban—Rash—Acarbose—type 2 diabetes mellitus	0.000253	0.00282	CcSEcCtD
Apixaban—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.000253	0.00281	CcSEcCtD
Apixaban—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000253	0.00281	CcSEcCtD
Apixaban—Eye disorder—Gliclazide—type 2 diabetes mellitus	0.000252	0.0028	CcSEcCtD
Apixaban—Loss of consciousness—Bromocriptine—type 2 diabetes mellitus	0.000251	0.0028	CcSEcCtD
Apixaban—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.00025	0.00279	CcSEcCtD
Apixaban—Haemoglobin—Valsartan—type 2 diabetes mellitus	0.000249	0.00277	CcSEcCtD
Apixaban—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000248	0.00276	CcSEcCtD
Apixaban—Nausea—Tolazamide—type 2 diabetes mellitus	0.000248	0.00276	CcSEcCtD
Apixaban—Haemorrhage—Valsartan—type 2 diabetes mellitus	0.000248	0.00276	CcSEcCtD
Apixaban—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000247	0.00275	CcSEcCtD
Apixaban—Haemoglobin—Orlistat—type 2 diabetes mellitus	0.000246	0.00274	CcSEcCtD
Apixaban—Haemorrhage—Orlistat—type 2 diabetes mellitus	0.000245	0.00272	CcSEcCtD
Apixaban—Urinary tract disorder—Valsartan—type 2 diabetes mellitus	0.000245	0.00272	CcSEcCtD
Apixaban—Rash—Nateglinide—type 2 diabetes mellitus	0.000244	0.00272	CcSEcCtD
Apixaban—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000244	0.00271	CcSEcCtD
Apixaban—Connective tissue disorder—Valsartan—type 2 diabetes mellitus	0.000243	0.00271	CcSEcCtD
Apixaban—Urethral disorder—Valsartan—type 2 diabetes mellitus	0.000243	0.0027	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.000242	0.00269	CcSEcCtD
Apixaban—Urinary tract disorder—Orlistat—type 2 diabetes mellitus	0.000242	0.00269	CcSEcCtD
Apixaban—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000242	0.00269	CcSEcCtD
Apixaban—Anaemia—Glyburide—type 2 diabetes mellitus	0.000242	0.00269	CcSEcCtD
Apixaban—Urethral disorder—Orlistat—type 2 diabetes mellitus	0.00024	0.00267	CcSEcCtD
Apixaban—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000239	0.00266	CcSEcCtD
Apixaban—Nausea—Acarbose—type 2 diabetes mellitus	0.000238	0.00265	CcSEcCtD
Apixaban—Hepatobiliary disease—Metformin—type 2 diabetes mellitus	0.000238	0.00264	CcSEcCtD
Apixaban—Nausea—Nateglinide—type 2 diabetes mellitus	0.00023	0.00256	CcSEcCtD
Apixaban—Shock—Bromocriptine—type 2 diabetes mellitus	0.00023	0.00255	CcSEcCtD
Apixaban—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000229	0.00255	CcSEcCtD
Apixaban—Liver function test abnormal—Ramipril—type 2 diabetes mellitus	0.000229	0.00255	CcSEcCtD
Apixaban—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000229	0.00255	CcSEcCtD
Apixaban—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000227	0.0306	CbGeAlD
Apixaban—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000227	0.00252	CcSEcCtD
Apixaban—Angiopathy—Valsartan—type 2 diabetes mellitus	0.000225	0.0025	CcSEcCtD
Apixaban—Breast disorder—Ramipril—type 2 diabetes mellitus	0.000224	0.0025	CcSEcCtD
Apixaban—Hepatobiliary disease—Irbesartan—type 2 diabetes mellitus	0.000224	0.0025	CcSEcCtD
Apixaban—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.000224	0.00249	CcSEcCtD
Apixaban—Epistaxis—Irbesartan—type 2 diabetes mellitus	0.000224	0.00249	CcSEcCtD
Apixaban—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000223	0.00248	CcSEcCtD
Apixaban—Mediastinal disorder—Valsartan—type 2 diabetes mellitus	0.000223	0.00248	CcSEcCtD
Apixaban—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000223	0.00248	CcSEcCtD
Apixaban—Connective tissue disorder—Metformin—type 2 diabetes mellitus	0.000222	0.00247	CcSEcCtD
Apixaban—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.000221	0.00246	CcSEcCtD
Apixaban—Mediastinal disorder—Orlistat—type 2 diabetes mellitus	0.000221	0.00245	CcSEcCtD
Apixaban—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000218	0.00243	CcSEcCtD
Apixaban—Anaemia—Gliclazide—type 2 diabetes mellitus	0.000217	0.00241	CcSEcCtD
Apixaban—Rash—Repaglinide—type 2 diabetes mellitus	0.000211	0.00235	CcSEcCtD
Apixaban—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000211	0.00235	CcSEcCtD
Apixaban—Eye disorder—Metformin—type 2 diabetes mellitus	0.000211	0.00235	CcSEcCtD
Apixaban—Epistaxis—Losartan—type 2 diabetes mellitus	0.000211	0.00234	CcSEcCtD
Apixaban—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.00021	0.00234	CcSEcCtD
Apixaban—Shock—Glyburide—type 2 diabetes mellitus	0.00021	0.00234	CcSEcCtD
Apixaban—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000209	0.00233	CcSEcCtD
Apixaban—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000209	0.00233	CcSEcCtD
Apixaban—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	0.000209	0.00233	CcSEcCtD
Apixaban—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000209	0.00232	CcSEcCtD
Apixaban—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.000209	0.00232	CcSEcCtD
Apixaban—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.000206	0.0023	CcSEcCtD
Apixaban—Angiopathy—Metformin—type 2 diabetes mellitus	0.000205	0.00228	CcSEcCtD
Apixaban—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000204	0.00227	CcSEcCtD
Apixaban—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000204	0.00227	CcSEcCtD
Apixaban—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000203	0.00226	CcSEcCtD
Apixaban—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000201	0.00224	CcSEcCtD
Apixaban—Rash—Rosiglitazone—type 2 diabetes mellitus	0.0002	0.00222	CcSEcCtD
Apixaban—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000199	0.00222	CcSEcCtD
Apixaban—Hypotension—Glyburide—type 2 diabetes mellitus	0.000199	0.00222	CcSEcCtD
Apixaban—Nausea—Repaglinide—type 2 diabetes mellitus	0.000199	0.00221	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000198	0.00221	CcSEcCtD
Apixaban—ABCG2—nephron tubule—type 2 diabetes mellitus	0.000197	0.0266	CbGeAlD
Apixaban—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000196	0.00218	CcSEcCtD
Apixaban—Syncope—Valsartan—type 2 diabetes mellitus	0.000193	0.00215	CcSEcCtD
Apixaban—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000193	0.00215	CcSEcCtD
Apixaban—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000192	0.00214	CcSEcCtD
Apixaban—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000192	0.00213	CcSEcCtD
Apixaban—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000191	0.00212	CcSEcCtD
Apixaban—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00019	0.00211	CcSEcCtD
Apixaban—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.00019	0.00211	CcSEcCtD
Apixaban—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000188	0.00209	CcSEcCtD
Apixaban—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000188	0.00209	CcSEcCtD
Apixaban—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000188	0.00209	CcSEcCtD
Apixaban—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000186	0.00207	CcSEcCtD
Apixaban—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000184	0.00205	CcSEcCtD
Apixaban—Dizziness—Glipizide—type 2 diabetes mellitus	0.000183	0.00204	CcSEcCtD
Apixaban—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000183	0.0247	CbGeAlD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000182	0.00203	CcSEcCtD
Apixaban—Angiopathy—Losartan—type 2 diabetes mellitus	0.000182	0.00202	CcSEcCtD
Apixaban—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000181	0.00201	CcSEcCtD
Apixaban—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000181	0.00201	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00018	0.002	CcSEcCtD
Apixaban—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000179	0.00199	CcSEcCtD
Apixaban—CYP2C8—kidney—type 2 diabetes mellitus	0.000178	0.024	CbGeAlD
Apixaban—Syncope—Metformin—type 2 diabetes mellitus	0.000176	0.00196	CcSEcCtD
Apixaban—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000176	0.00196	CcSEcCtD
Apixaban—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000176	0.00195	CcSEcCtD
Apixaban—Rash—Glipizide—type 2 diabetes mellitus	0.000175	0.00194	CcSEcCtD
Apixaban—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000175	0.00194	CcSEcCtD
Apixaban—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000174	0.00194	CcSEcCtD
Apixaban—Shock—Valsartan—type 2 diabetes mellitus	0.000173	0.00193	CcSEcCtD
Apixaban—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000173	0.00192	CcSEcCtD
Apixaban—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000173	0.00192	CcSEcCtD
Apixaban—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000172	0.00192	CcSEcCtD
Apixaban—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000171	0.00191	CcSEcCtD
Apixaban—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000171	0.0019	CcSEcCtD
Apixaban—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000171	0.0019	CcSEcCtD
Apixaban—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000171	0.0019	CcSEcCtD
Apixaban—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000171	0.0019	CcSEcCtD
Apixaban—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000169	0.00188	CcSEcCtD
Apixaban—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000169	0.00188	CcSEcCtD
Apixaban—Syncope—Irbesartan—type 2 diabetes mellitus	0.000166	0.00185	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000166	0.00185	CcSEcCtD
Apixaban—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000165	0.00184	CcSEcCtD
Apixaban—Nausea—Glipizide—type 2 diabetes mellitus	0.000165	0.00183	CcSEcCtD
Apixaban—Hypotension—Valsartan—type 2 diabetes mellitus	0.000164	0.00183	CcSEcCtD
Apixaban—Rash—Glimepiride—type 2 diabetes mellitus	0.000163	0.00181	CcSEcCtD
Apixaban—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000163	0.00181	CcSEcCtD
Apixaban—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000163	0.00181	CcSEcCtD
Apixaban—Rash—Sitagliptin—type 2 diabetes mellitus	0.000163	0.00181	CcSEcCtD
Apixaban—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000162	0.00181	CcSEcCtD
Apixaban—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000162	0.0218	CbGeAlD
Apixaban—Anaemia—Losartan—type 2 diabetes mellitus	0.000161	0.00179	CcSEcCtD
Apixaban—CYP3A5—kidney—type 2 diabetes mellitus	0.000161	0.0217	CbGeAlD
Apixaban—CYP3A5—pancreas—type 2 diabetes mellitus	0.00016	0.0215	CbGeAlD
Apixaban—Shock—Metformin—type 2 diabetes mellitus	0.000158	0.00175	CcSEcCtD
Apixaban—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000157	0.00175	CcSEcCtD
Apixaban—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000157	0.00175	CcSEcCtD
Apixaban—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000157	0.00175	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000157	0.00174	CcSEcCtD
Apixaban—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000157	0.0211	CbGeAlD
Apixaban—Syncope—Losartan—type 2 diabetes mellitus	0.000156	0.00174	CcSEcCtD
Apixaban—ABCG2—adipose tissue—type 2 diabetes mellitus	0.000156	0.021	CbGeAlD
Apixaban—Skin disorder—Metformin—type 2 diabetes mellitus	0.000156	0.00173	CcSEcCtD
Apixaban—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000155	0.00173	CcSEcCtD
Apixaban—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000155	0.00172	CcSEcCtD
Apixaban—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000154	0.00172	CcSEcCtD
Apixaban—Nausea—Glimepiride—type 2 diabetes mellitus	0.000154	0.00171	CcSEcCtD
Apixaban—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000153	0.00171	CcSEcCtD
Apixaban—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000153	0.0017	CcSEcCtD
Apixaban—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000152	0.00169	CcSEcCtD
Apixaban—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000151	0.00168	CcSEcCtD
Apixaban—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.00015	0.00167	CcSEcCtD
Apixaban—Hypotension—Metformin—type 2 diabetes mellitus	0.00015	0.00167	CcSEcCtD
Apixaban—Shock—Irbesartan—type 2 diabetes mellitus	0.000149	0.00166	CcSEcCtD
Apixaban—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000148	0.00165	CcSEcCtD
Apixaban—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000148	0.00165	CcSEcCtD
Apixaban—Rash—Bromocriptine—type 2 diabetes mellitus	0.000147	0.00164	CcSEcCtD
Apixaban—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000147	0.00164	CcSEcCtD
Apixaban—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000147	0.00163	CcSEcCtD
Apixaban—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000145	0.0195	CbGeAlD
Apixaban—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000142	0.00158	CcSEcCtD
Apixaban—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000141	0.00157	CcSEcCtD
Apixaban—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000141	0.00157	CcSEcCtD
Apixaban—Shock—Losartan—type 2 diabetes mellitus	0.00014	0.00156	CcSEcCtD
Apixaban—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.00014	0.00155	CcSEcCtD
Apixaban—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000139	0.00155	CcSEcCtD
Apixaban—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000139	0.00154	CcSEcCtD
Apixaban—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000138	0.00154	CcSEcCtD
Apixaban—Rash—Glyburide—type 2 diabetes mellitus	0.000135	0.0015	CcSEcCtD
Apixaban—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000134	0.0015	CcSEcCtD
Apixaban—Syncope—Ramipril—type 2 diabetes mellitus	0.000134	0.00149	CcSEcCtD
Apixaban—Hypotension—Losartan—type 2 diabetes mellitus	0.000133	0.00148	CcSEcCtD
Apixaban—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000131	0.00146	CcSEcCtD
Apixaban—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000131	0.00145	CcSEcCtD
Apixaban—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00013	0.00144	CcSEcCtD
Apixaban—CYP2C19—liver—type 2 diabetes mellitus	0.000129	0.0174	CbGeAlD
Apixaban—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000128	0.00143	CcSEcCtD
Apixaban—Nausea—Glyburide—type 2 diabetes mellitus	0.000127	0.00141	CcSEcCtD
Apixaban—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000127	0.00141	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000126	0.00141	CcSEcCtD
Apixaban—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000122	0.00136	CcSEcCtD
Apixaban—Rash—Gliclazide—type 2 diabetes mellitus	0.000121	0.00134	CcSEcCtD
Apixaban—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000121	0.0163	CbGeAlD
Apixaban—CYP3A4—kidney—type 2 diabetes mellitus	0.000121	0.0163	CbGeAlD
Apixaban—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000121	0.00134	CcSEcCtD
Apixaban—Shock—Ramipril—type 2 diabetes mellitus	0.00012	0.00134	CcSEcCtD
Apixaban—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.00012	0.00133	CcSEcCtD
Apixaban—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.00012	0.00133	CcSEcCtD
Apixaban—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000119	0.00132	CcSEcCtD
Apixaban—Dizziness—Valsartan—type 2 diabetes mellitus	0.000116	0.00129	CcSEcCtD
Apixaban—Dizziness—Orlistat—type 2 diabetes mellitus	0.000115	0.00128	CcSEcCtD
Apixaban—Hypotension—Ramipril—type 2 diabetes mellitus	0.000114	0.00127	CcSEcCtD
Apixaban—Nausea—Gliclazide—type 2 diabetes mellitus	0.000114	0.00127	CcSEcCtD
Apixaban—CYP2C8—liver—type 2 diabetes mellitus	0.000113	0.0152	CbGeAlD
Apixaban—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000111	0.00124	CcSEcCtD
Apixaban—Rash—Valsartan—type 2 diabetes mellitus	0.000111	0.00123	CcSEcCtD
Apixaban—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000111	0.00123	CcSEcCtD
Apixaban—Rash—Orlistat—type 2 diabetes mellitus	0.00011	0.00122	CcSEcCtD
Apixaban—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00011	0.00122	CcSEcCtD
Apixaban—ABCG2—liver—type 2 diabetes mellitus	0.00011	0.0148	CbGeAlD
Apixaban—Dizziness—Metformin—type 2 diabetes mellitus	0.000106	0.00118	CcSEcCtD
Apixaban—CYP1A2—liver—type 2 diabetes mellitus	0.000105	0.0142	CbGeAlD
Apixaban—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000105	0.00117	CcSEcCtD
Apixaban—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000105	0.00117	CcSEcCtD
Apixaban—Nausea—Valsartan—type 2 diabetes mellitus	0.000105	0.00116	CcSEcCtD
Apixaban—Nausea—Orlistat—type 2 diabetes mellitus	0.000103	0.00115	CcSEcCtD
Apixaban—ABCB1—retina—type 2 diabetes mellitus	0.000103	0.0139	CbGeAlD
Apixaban—CYP3A5—liver—type 2 diabetes mellitus	0.000102	0.0137	CbGeAlD
Apixaban—Rash—Metformin—type 2 diabetes mellitus	0.000101	0.00112	CcSEcCtD
Apixaban—Dermatitis—Metformin—type 2 diabetes mellitus	0.000101	0.00112	CcSEcCtD
Apixaban—CYP2C9—liver—type 2 diabetes mellitus	0.0001	0.0135	CbGeAlD
Apixaban—Dizziness—Irbesartan—type 2 diabetes mellitus	0.0001	0.00111	CcSEcCtD
Apixaban—ABCB1—nephron tubule—type 2 diabetes mellitus	9.72e-05	0.0131	CbGeAlD
Apixaban—Rash—Irbesartan—type 2 diabetes mellitus	9.54e-05	0.00106	CcSEcCtD
Apixaban—Dermatitis—Irbesartan—type 2 diabetes mellitus	9.53e-05	0.00106	CcSEcCtD
Apixaban—Nausea—Metformin—type 2 diabetes mellitus	9.52e-05	0.00106	CcSEcCtD
Apixaban—Dizziness—Losartan—type 2 diabetes mellitus	9.41e-05	0.00105	CcSEcCtD
Apixaban—Hypersensitivity—Ramipril—type 2 diabetes mellitus	8.99e-05	0.001	CcSEcCtD
Apixaban—Nausea—Irbesartan—type 2 diabetes mellitus	8.98e-05	0.001	CcSEcCtD
Apixaban—Rash—Losartan—type 2 diabetes mellitus	8.97e-05	0.000999	CcSEcCtD
Apixaban—Dermatitis—Losartan—type 2 diabetes mellitus	8.97e-05	0.000998	CcSEcCtD
Apixaban—ABCB1—cardiovascular system—type 2 diabetes mellitus	8.73e-05	0.0118	CbGeAlD
Apixaban—ABCB1—kidney—type 2 diabetes mellitus	8.55e-05	0.0115	CbGeAlD
Apixaban—ABCB1—pancreas—type 2 diabetes mellitus	8.49e-05	0.0114	CbGeAlD
Apixaban—Nausea—Losartan—type 2 diabetes mellitus	8.45e-05	0.000941	CcSEcCtD
Apixaban—ABCB1—cortex of kidney—type 2 diabetes mellitus	8.32e-05	0.0112	CbGeAlD
Apixaban—Dizziness—Ramipril—type 2 diabetes mellitus	8.07e-05	0.000898	CcSEcCtD
Apixaban—ABCB1—adipose tissue—type 2 diabetes mellitus	7.7e-05	0.0104	CbGeAlD
Apixaban—Rash—Ramipril—type 2 diabetes mellitus	7.7e-05	0.000856	CcSEcCtD
Apixaban—Dermatitis—Ramipril—type 2 diabetes mellitus	7.69e-05	0.000855	CcSEcCtD
Apixaban—CYP3A4—liver—type 2 diabetes mellitus	7.63e-05	0.0103	CbGeAlD
Apixaban—Nausea—Ramipril—type 2 diabetes mellitus	7.25e-05	0.000807	CcSEcCtD
Apixaban—ABCB1—liver—type 2 diabetes mellitus	5.4e-05	0.00728	CbGeAlD
Apixaban—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	4.66e-06	5.75e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	4.66e-06	5.75e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	4.66e-06	5.75e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	4.65e-06	5.74e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	4.62e-06	5.71e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	4.62e-06	5.71e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PPARG—type 2 diabetes mellitus	4.58e-06	5.66e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	4.58e-06	5.66e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	4.57e-06	5.65e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	4.56e-06	5.63e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	4.55e-06	5.62e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	4.55e-06	5.62e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	4.53e-06	5.6e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	4.51e-06	5.57e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	4.51e-06	5.57e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	4.5e-06	5.57e-05	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—AKT1—type 2 diabetes mellitus	4.5e-06	5.56e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	4.49e-06	5.55e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—INS—type 2 diabetes mellitus	4.49e-06	5.55e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.48e-06	5.54e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.47e-06	5.52e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	4.46e-06	5.52e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.46e-06	5.51e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.44e-06	5.48e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	4.44e-06	5.48e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	4.44e-06	5.48e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	4.44e-06	5.48e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	4.43e-06	5.48e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	4.43e-06	5.47e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	4.43e-06	5.47e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	4.41e-06	5.45e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	4.4e-06	5.44e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	4.39e-06	5.43e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	4.38e-06	5.42e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	4.33e-06	5.35e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	4.32e-06	5.34e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	4.32e-06	5.34e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.31e-06	5.33e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.31e-06	5.33e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.31e-06	5.33e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.31e-06	5.33e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	4.28e-06	5.29e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.27e-06	5.28e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	4.27e-06	5.28e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	4.27e-06	5.28e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	4.26e-06	5.26e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	4.25e-06	5.26e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	4.22e-06	5.21e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	4.21e-06	5.2e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	4.21e-06	5.2e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	4.2e-06	5.19e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.13e-06	5.11e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ALB—type 2 diabetes mellitus	4.12e-06	5.09e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	4.11e-06	5.07e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.08e-06	5.05e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	4.08e-06	5.04e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	4.05e-06	5e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	4.04e-06	4.99e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	4.04e-06	4.99e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.99e-06	4.93e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	3.98e-06	4.92e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	3.98e-06	4.92e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	3.98e-06	4.92e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	3.97e-06	4.91e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	3.96e-06	4.9e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	3.94e-06	4.87e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.94e-06	4.87e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	3.9e-06	4.83e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	3.89e-06	4.81e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	3.87e-06	4.78e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	3.84e-06	4.75e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.84e-06	4.75e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.82e-06	4.72e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	3.82e-06	4.72e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.82e-06	4.72e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	3.81e-06	4.71e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.8e-06	4.69e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	3.8e-06	4.69e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	3.79e-06	4.68e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	3.78e-06	4.67e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	3.77e-06	4.65e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.75e-06	4.63e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	3.72e-06	4.6e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.72e-06	4.6e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	3.72e-06	4.6e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	3.71e-06	4.58e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	3.7e-06	4.57e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	3.66e-06	4.52e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	3.65e-06	4.51e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	3.64e-06	4.5e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.64e-06	4.5e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	3.6e-06	4.45e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.6e-06	4.45e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.59e-06	4.43e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3.55e-06	4.39e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	3.54e-06	4.37e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.51e-06	4.34e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.51e-06	4.34e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.51e-06	4.34e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	3.5e-06	4.33e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.49e-06	4.31e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	3.48e-06	4.3e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.48e-06	4.3e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	3.47e-06	4.29e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	3.46e-06	4.28e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	3.45e-06	4.27e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	3.45e-06	4.26e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.45e-06	4.26e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.44e-06	4.26e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	3.44e-06	4.25e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.42e-06	4.23e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.42e-06	4.23e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.42e-06	4.23e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	3.42e-06	4.22e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.4e-06	4.2e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	3.4e-06	4.2e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	3.39e-06	4.19e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	3.39e-06	4.19e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.34e-06	4.13e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	3.33e-06	4.11e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	3.32e-06	4.1e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	3.32e-06	4.1e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	3.31e-06	4.09e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.3e-06	4.08e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	3.3e-06	4.08e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	3.28e-06	4.05e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	3.27e-06	4.05e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	3.26e-06	4.03e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	3.26e-06	4.03e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	3.23e-06	3.99e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	3.22e-06	3.99e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	3.22e-06	3.98e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	3.22e-06	3.98e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.18e-06	3.93e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	3.17e-06	3.91e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	3.13e-06	3.87e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	3.1e-06	3.83e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3.09e-06	3.82e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.07e-06	3.79e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.07e-06	3.79e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.07e-06	3.79e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	3.07e-06	3.79e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	3.05e-06	3.77e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.01e-06	3.72e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	3.01e-06	3.72e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	2.99e-06	3.7e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.99e-06	3.69e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.97e-06	3.67e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	2.97e-06	3.67e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.97e-06	3.67e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.97e-06	3.67e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.96e-06	3.66e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	2.95e-06	3.65e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.92e-06	3.61e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.92e-06	3.61e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	2.92e-06	3.61e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.91e-06	3.6e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	2.9e-06	3.58e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.88e-06	3.56e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	2.85e-06	3.52e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.85e-06	3.52e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	2.84e-06	3.51e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	2.84e-06	3.51e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	2.83e-06	3.5e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	2.82e-06	3.49e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	2.82e-06	3.49e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.81e-06	3.47e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.81e-06	3.47e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.8e-06	3.46e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	2.79e-06	3.44e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.78e-06	3.43e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.78e-06	3.43e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.76e-06	3.41e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.71e-06	3.35e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.71e-06	3.35e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.66e-06	3.29e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.66e-06	3.29e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.66e-06	3.29e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.65e-06	3.28e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.65e-06	3.27e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.64e-06	3.26e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.62e-06	3.24e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	2.58e-06	3.19e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.57e-06	3.18e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	2.55e-06	3.16e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.54e-06	3.14e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.54e-06	3.13e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.49e-06	3.07e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.48e-06	3.06e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	2.44e-06	3.02e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	2.44e-06	3.02e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.44e-06	3.01e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.43e-06	3e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.39e-06	2.95e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.32e-06	2.86e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.31e-06	2.86e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.29e-06	2.84e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.29e-06	2.84e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.28e-06	2.82e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.28e-06	2.82e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.28e-06	2.81e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.27e-06	2.8e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.27e-06	2.8e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.25e-06	2.79e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.24e-06	2.77e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	2.24e-06	2.76e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.23e-06	2.75e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.19e-06	2.7e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.18e-06	2.7e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.18e-06	2.7e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.13e-06	2.63e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.13e-06	2.63e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.13e-06	2.63e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.09e-06	2.58e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.08e-06	2.57e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.04e-06	2.53e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.04e-06	2.52e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	2e-06	2.47e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.99e-06	2.46e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.99e-06	2.46e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.98e-06	2.45e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.98e-06	2.44e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.96e-06	2.42e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.95e-06	2.41e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.94e-06	2.4e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.88e-06	2.32e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.85e-06	2.28e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.82e-06	2.25e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	1.81e-06	2.24e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.79e-06	2.21e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.78e-06	2.2e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.76e-06	2.17e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.75e-06	2.16e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.73e-06	2.14e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.7e-06	2.1e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.7e-06	2.1e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.55e-06	1.92e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.53e-06	1.88e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.5e-06	1.85e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.37e-06	1.69e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.31e-06	1.62e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.31e-06	1.62e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.3e-06	1.6e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.2e-06	1.48e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.12e-06	1.39e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1e-06	1.24e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	9.79e-07	1.21e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	9.14e-07	1.13e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	7.81e-07	9.66e-06	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.03e-07	7.45e-06	CbGpPWpGaD
